Early Optical Coherence Tomography Biomarkers for Selected Retinal Diseases-A Review

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2023 Jul 29

PMID 37510188

Authors

Ewa Gozdziewska

Malgorzata Wichrowska

Jaroslaw Kociecki

Affiliations

Soon will be listed here.

Abstract

Optical coherence tomography (OCT) is a non-invasive, easily accessible imaging technique that enables diagnosing several retinal diseases at various stages of development. This review discusses early OCT findings as non-invasive imaging biomarkers for predicting the future development of selected retinal diseases, with emphasis on age-related macular degeneration, macular telangiectasia, and drug-induced maculopathies. Practitioners, by being able to predict the development of many conditions and start treatment at the earliest stage, may thus achieve better treatment outcomes.

Citing Articles

Ocular findings in Jansen metaphyseal chondrodysplasia.

Obiezu F, Magone De Quadros Costa M, Huryn L, Pan K, Almpani K, Ninan A JBMR Plus. 2024; 8(9):ziae089.

PMID: 39108358 PMC: 11299511. DOI: 10.1093/jbmrpl/ziae089.

A Comprehensive Review of AI Diagnosis Strategies for Age-Related Macular Degeneration (AMD).

Abd El-Khalek A, Balaha H, Sewelam A, Ghazal M, Khalil A, Abo-Elsoud M Bioengineering (Basel). 2024; 11(7).

PMID: 39061793 PMC: 11273790. DOI: 10.3390/bioengineering11070711.

References

Yun S, Tearney G, Bouma B, Park B, de Boer J . High-speed spectral-domain optical coherence tomography at 1.3 mum wavelength. Opt Express. 2009; 11(26):3598-604. PMC: 2713046. DOI: 10.1364/oe.11.003598. View

Coscas G, De Benedetto U, Coscas F, Li Calzi C, Vismara S, Roudot-Thoraval F . Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica. 2012; 229(1):32-7. DOI: 10.1159/000342159. View

Iovino C, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Govetto A . Choroidal Vascularity Index: An In-Depth Analysis of This Novel Optical Coherence Tomography Parameter. J Clin Med. 2020; 9(2). PMC: 7074450. DOI: 10.3390/jcm9020595. View

Spaide R, Fujimoto J, Waheed N, Sadda S, Staurenghi G . Optical coherence tomography angiography. Prog Retin Eye Res. 2017; 64:1-55. PMC: 6404988. DOI: 10.1016/j.preteyeres.2017.11.003. View

Lamin A, Dubis A, Sivaprasad S . Changes in macular drusen parameters preceding the development of neovascular age-related macular degeneration. Eye (Lond). 2019; 33(6):910-916. PMC: 6707230. DOI: 10.1038/s41433-019-0338-x. View

Leitgeb R, Hitzenberger C, Fercher A . Performance of fourier domain vs. time domain optical coherence tomography. Opt Express. 2009; 11(8):889-94. DOI: 10.1364/oe.11.000889. View

Spaide R, Ooto S, Curcio C . Subretinal drusenoid deposits AKA pseudodrusen. Surv Ophthalmol. 2018; 63(6):782-815. DOI: 10.1016/j.survophthal.2018.05.005. View

Schick T, Ersoy L, Hoyng C, Kirchhof B, Liakopoulos S . Phenotype Characteristics of Fellow Eyes in Patients With Early Onset of Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2015; 56(12):7269-73. DOI: 10.1167/iovs.15-16989. View

Nag T, Wadhwa S . Ultrastructure of the human retina in aging and various pathological states. Micron. 2012; 43(7):759-81. DOI: 10.1016/j.micron.2012.01.011. View

10.

Alex D, Giridhar A, Gopalakrishnan M, Manayath G, Amar S, Raman R . EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1). Retina. 2020; 41(3):471-479. DOI: 10.1097/IAE.0000000000002954. View

11.

Corradetti G, Violanti S, Au A, Sarraf D . Wide field retinal imaging and the detection of drug associated retinal toxicity. Int J Retina Vitreous. 2020; 5(Suppl 1):26. PMC: 6907121. DOI: 10.1186/s40942-019-0172-0. View

12.

Bek T, Klug S . Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye. Graefes Arch Clin Exp Ophthalmol. 2018; 256(11):2061-2068. DOI: 10.1007/s00417-018-4100-z. View

13.

GASS J, Oyakawa R . Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982; 100(5):769-80. DOI: 10.1001/archopht.1982.01030030773010. View

14.

Zeimer M, Gutfleisch M, Heimes B, Spital G, Lommatzsch A, Pauleikhoff D . ASSOCIATION BETWEEN CHANGES IN MACULAR VASCULATURE IN OPTICAL COHERENCE TOMOGRAPHY- AND FLUORESCEIN- ANGIOGRAPHY AND DISTRIBUTION OF MACULAR PIGMENT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina. 2015; 35(11):2307-16. DOI: 10.1097/IAE.0000000000000868. View

15.

Nagasaka Y, Ito Y, Ueno S, Terasaki H . Number of Hyperreflective Foci in the Outer Retina Correlates with Inflammation and Photoreceptor Degeneration in Retinitis Pigmentosa. Ophthalmol Retina. 2019; 2(7):726-734. DOI: 10.1016/j.oret.2017.07.020. View

16.

Yannuzzi L, Bardal A, Freund K, Chen K, Eandi C, Blodi B . Idiopathic macular telangiectasia. Arch Ophthalmol. 2006; 124(4):450-60. DOI: 10.1001/archopht.124.4.450. View

17.

Kang D, Yoon E, Nam K, Yun C . Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits. BMC Ophthalmol. 2022; 22(1):304. PMC: 9284825. DOI: 10.1186/s12886-022-02518-4. View

18.

Kedarisetti K, Narayanan R, Stewart M, Reddy Gurram N, Khanani A . Macular Telangiectasia Type 2: A Comprehensive Review. Clin Ophthalmol. 2022; 16:3297-3309. PMC: 9553319. DOI: 10.2147/OPTH.S373538. View

19.

Sharma A, Parachuri N, Kumar N, Bandello F, Kuppermann B, Loewenstein A . Terms non-exudative and non-neovascular: awaiting entry at the doors of AMD reclassification. Graefes Arch Clin Exp Ophthalmol. 2021; 259(6):1381-1383. DOI: 10.1007/s00417-021-05164-6. View

20.

Baumuller S, Charbel Issa P, Scholl H, Schmitz-Valckenberg S, Holz F . Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2. Ophthalmology. 2010; 117(11):2162-8. DOI: 10.1016/j.ophtha.2010.02.014. View